Maryrose P. Sullivan, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle, Smooth | 12 | 2022 | 926 | 1.600 |
Why?
|
Urinary Bladder | 11 | 2020 | 1150 | 1.320 |
Why?
|
Dementia | 11 | 2024 | 2679 | 1.290 |
Why?
|
Urinary Bladder, Overactive | 5 | 2017 | 115 | 0.950 |
Why?
|
Muscle Contraction | 10 | 2022 | 1197 | 0.940 |
Why?
|
Caveolae | 3 | 2012 | 55 | 0.860 |
Why?
|
Fibroins | 6 | 2020 | 57 | 0.840 |
Why?
|
Myenteric Plexus | 1 | 2021 | 49 | 0.750 |
Why?
|
Urodynamics | 8 | 2020 | 346 | 0.670 |
Why?
|
Gastric Fundus | 2 | 2021 | 37 | 0.650 |
Why?
|
Stomach Diseases | 1 | 2019 | 134 | 0.600 |
Why?
|
Gastric Emptying | 1 | 2019 | 242 | 0.570 |
Why?
|
Stomach | 1 | 2021 | 694 | 0.550 |
Why?
|
Urinary Bladder Neck Obstruction | 2 | 2017 | 81 | 0.530 |
Why?
|
Clitoris | 1 | 2015 | 35 | 0.510 |
Why?
|
Coitus | 1 | 2015 | 131 | 0.490 |
Why?
|
Myosin Type V | 1 | 2014 | 33 | 0.460 |
Why?
|
Interstitial Cells of Cajal | 1 | 2013 | 23 | 0.450 |
Why?
|
Muscle Relaxation | 1 | 2014 | 138 | 0.450 |
Why?
|
Caveolin 1 | 2 | 2012 | 255 | 0.450 |
Why?
|
Tissue Scaffolds | 6 | 2020 | 934 | 0.450 |
Why?
|
Neuropilin-2 | 3 | 2022 | 55 | 0.450 |
Why?
|
Anthropology, Cultural | 2 | 2024 | 102 | 0.450 |
Why?
|
Esophagoplasty | 3 | 2020 | 48 | 0.440 |
Why?
|
Penis | 1 | 2014 | 212 | 0.420 |
Why?
|
Diabetes Complications | 1 | 2019 | 1317 | 0.410 |
Why?
|
Inosine | 3 | 2018 | 130 | 0.410 |
Why?
|
Caregivers | 7 | 2024 | 2232 | 0.410 |
Why?
|
Caveolins | 1 | 2012 | 101 | 0.400 |
Why?
|
Receptors, Purinergic | 1 | 2012 | 66 | 0.400 |
Why?
|
Myosin Heavy Chains | 1 | 2014 | 404 | 0.400 |
Why?
|
Spinal Cord Injuries | 5 | 2018 | 924 | 0.390 |
Why?
|
Urinary Incontinence | 1 | 2015 | 489 | 0.380 |
Why?
|
Urinary Retention | 1 | 2012 | 106 | 0.370 |
Why?
|
Rural Health Services | 2 | 2007 | 382 | 0.360 |
Why?
|
Enteric Nervous System | 1 | 2013 | 212 | 0.360 |
Why?
|
Regeneration | 5 | 2020 | 1508 | 0.310 |
Why?
|
Synaptic Transmission | 1 | 2013 | 1172 | 0.290 |
Why?
|
Wales | 2 | 2024 | 87 | 0.280 |
Why?
|
Social Support | 4 | 2024 | 2167 | 0.240 |
Why?
|
Urinary Bladder Diseases | 2 | 2018 | 167 | 0.240 |
Why?
|
Nitric Oxide | 1 | 2014 | 2133 | 0.240 |
Why?
|
Activities of Daily Living | 2 | 2024 | 2420 | 0.240 |
Why?
|
Neurosurgical Procedures | 1 | 2015 | 2070 | 0.240 |
Why?
|
Family Practice | 1 | 2007 | 509 | 0.230 |
Why?
|
Geriatric Psychiatry | 1 | 2004 | 71 | 0.230 |
Why?
|
Community Mental Health Services | 1 | 2007 | 392 | 0.220 |
Why?
|
Independent Living | 2 | 2024 | 579 | 0.210 |
Why?
|
Community-Institutional Relations | 1 | 2004 | 206 | 0.210 |
Why?
|
England | 1 | 2023 | 527 | 0.200 |
Why?
|
Narration | 1 | 2024 | 219 | 0.200 |
Why?
|
Synaptotagmin II | 1 | 2021 | 14 | 0.200 |
Why?
|
Health Services for the Aged | 1 | 2004 | 259 | 0.190 |
Why?
|
Synaptotagmin I | 1 | 2021 | 33 | 0.190 |
Why?
|
Health Services, Indigenous | 1 | 2002 | 47 | 0.190 |
Why?
|
Urination Disorders | 1 | 2002 | 238 | 0.190 |
Why?
|
Atrophy | 2 | 2024 | 1631 | 0.190 |
Why?
|
Vision Disorders | 2 | 2019 | 1088 | 0.180 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5835 | 0.180 |
Why?
|
Urinary Tract Physiological Phenomena | 1 | 2020 | 11 | 0.180 |
Why?
|
Gastrointestinal Motility | 1 | 2022 | 234 | 0.180 |
Why?
|
Angiotensin II | 1 | 2003 | 848 | 0.180 |
Why?
|
Case Management | 1 | 2002 | 272 | 0.170 |
Why?
|
Botulinum Toxins | 1 | 2021 | 188 | 0.170 |
Why?
|
Rats, Sprague-Dawley | 7 | 2018 | 8163 | 0.170 |
Why?
|
Loneliness | 1 | 2021 | 203 | 0.160 |
Why?
|
Silk | 2 | 2020 | 90 | 0.160 |
Why?
|
Urinary Bladder, Neurogenic | 2 | 2018 | 173 | 0.160 |
Why?
|
Animals | 25 | 2022 | 168253 | 0.160 |
Why?
|
Rodentia | 1 | 2020 | 261 | 0.160 |
Why?
|
Renin-Angiotensin System | 1 | 2003 | 737 | 0.160 |
Why?
|
DNA | 1 | 2012 | 7208 | 0.160 |
Why?
|
Rats | 9 | 2018 | 23712 | 0.150 |
Why?
|
Urethra | 3 | 2007 | 404 | 0.150 |
Why?
|
Indians, North American | 1 | 2002 | 353 | 0.150 |
Why?
|
Benchmarking | 1 | 2004 | 1045 | 0.150 |
Why?
|
Tissue Engineering | 3 | 2020 | 1870 | 0.150 |
Why?
|
Postprandial Period | 1 | 2019 | 315 | 0.140 |
Why?
|
Gastroparesis | 1 | 2019 | 136 | 0.140 |
Why?
|
Peer Group | 1 | 2022 | 684 | 0.140 |
Why?
|
Receptor, Adenosine A2A | 1 | 2017 | 128 | 0.140 |
Why?
|
Kidney | 1 | 2012 | 7046 | 0.130 |
Why?
|
Rural Population | 1 | 2007 | 2279 | 0.130 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2021 | 2509 | 0.120 |
Why?
|
Mucous Membrane | 1 | 2018 | 657 | 0.120 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11900 | 0.120 |
Why?
|
Colon | 1 | 2022 | 1791 | 0.120 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 802 | 0.110 |
Why?
|
Nitric Oxide Donors | 1 | 2014 | 124 | 0.110 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2014 | 260 | 0.110 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2014 | 174 | 0.110 |
Why?
|
Alzheimer Disease | 4 | 2024 | 8579 | 0.110 |
Why?
|
Disease Models, Animal | 8 | 2018 | 18216 | 0.110 |
Why?
|
Mice, Inbred DBA | 1 | 2014 | 621 | 0.110 |
Why?
|
Aging | 1 | 2012 | 8689 | 0.110 |
Why?
|
Mental Health Services | 1 | 2004 | 1730 | 0.100 |
Why?
|
Rats, Inbred WKY | 1 | 2012 | 151 | 0.100 |
Why?
|
Caveolin 3 | 1 | 2012 | 24 | 0.100 |
Why?
|
Rats, Inbred SHR | 1 | 2012 | 186 | 0.100 |
Why?
|
Caveolin 2 | 1 | 2012 | 25 | 0.100 |
Why?
|
Laminectomy | 1 | 2013 | 225 | 0.100 |
Why?
|
Swine | 5 | 2020 | 5915 | 0.100 |
Why?
|
Evoked Potentials | 1 | 2018 | 1037 | 0.100 |
Why?
|
Ureter | 2 | 2004 | 367 | 0.090 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 256 | 0.090 |
Why?
|
Esophagus | 1 | 2017 | 1030 | 0.090 |
Why?
|
Spinal Cord Compression | 1 | 2013 | 235 | 0.090 |
Why?
|
Qualitative Research | 4 | 2024 | 3008 | 0.090 |
Why?
|
Hyperglycemia | 1 | 2019 | 1371 | 0.090 |
Why?
|
Male | 20 | 2024 | 360035 | 0.090 |
Why?
|
Quality of Life | 4 | 2024 | 13338 | 0.090 |
Why?
|
Kidney Function Tests | 1 | 2012 | 675 | 0.080 |
Why?
|
Signal Transduction | 2 | 2012 | 23397 | 0.080 |
Why?
|
Humans | 30 | 2024 | 760437 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3873 | 0.080 |
Why?
|
Isometric Contraction | 2 | 2018 | 150 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2024 | 58859 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 1967 | 0.070 |
Why?
|
Cerebral Cortex | 2 | 2024 | 5764 | 0.070 |
Why?
|
Wound Healing | 1 | 2017 | 2799 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2021 | 12785 | 0.070 |
Why?
|
Ontario | 1 | 2007 | 399 | 0.060 |
Why?
|
Models, Biological | 2 | 2017 | 9462 | 0.060 |
Why?
|
Blotting, Western | 1 | 2012 | 5031 | 0.060 |
Why?
|
Blood Glucose | 1 | 2019 | 6380 | 0.060 |
Why?
|
Physicians, Family | 1 | 2007 | 349 | 0.060 |
Why?
|
Mice | 6 | 2022 | 81402 | 0.060 |
Why?
|
Interviews as Topic | 2 | 2024 | 2683 | 0.060 |
Why?
|
Aged | 9 | 2024 | 168840 | 0.050 |
Why?
|
Female | 15 | 2024 | 391875 | 0.050 |
Why?
|
Population Dynamics | 1 | 2004 | 307 | 0.050 |
Why?
|
Carbachol | 1 | 2022 | 223 | 0.050 |
Why?
|
New Mexico | 1 | 2002 | 83 | 0.050 |
Why?
|
Arizona | 1 | 2002 | 107 | 0.050 |
Why?
|
Self-Help Groups | 1 | 2023 | 189 | 0.050 |
Why?
|
Losartan | 1 | 2003 | 265 | 0.050 |
Why?
|
Urinary Incontinence, Stress | 1 | 2003 | 181 | 0.050 |
Why?
|
Medicine, Traditional | 1 | 2002 | 88 | 0.050 |
Why?
|
Mentors | 1 | 2007 | 660 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4355 | 0.050 |
Why?
|
Needs Assessment | 1 | 2007 | 1139 | 0.050 |
Why?
|
Interprofessional Relations | 1 | 2007 | 991 | 0.040 |
Why?
|
rho-Associated Kinases | 2 | 2012 | 280 | 0.040 |
Why?
|
Urinary Tract Infections | 1 | 2007 | 806 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2021 | 421 | 0.040 |
Why?
|
Long-Term Care | 1 | 2004 | 633 | 0.040 |
Why?
|
Gene Expression | 1 | 2012 | 7582 | 0.040 |
Why?
|
Urinary Tract | 1 | 2002 | 313 | 0.040 |
Why?
|
Canada | 1 | 2004 | 2119 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 29551 | 0.040 |
Why?
|
Nurse Practitioners | 1 | 2002 | 270 | 0.040 |
Why?
|
Social Isolation | 1 | 2021 | 364 | 0.040 |
Why?
|
Receptors, Purinergic P1 | 1 | 2018 | 108 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 22121 | 0.040 |
Why?
|
Electric Stimulation | 1 | 2003 | 1735 | 0.040 |
Why?
|
Life Change Events | 1 | 2023 | 952 | 0.040 |
Why?
|
Abdomen | 1 | 2004 | 1127 | 0.040 |
Why?
|
Receptors, Muscarinic | 1 | 2018 | 157 | 0.040 |
Why?
|
Caustics | 1 | 2017 | 32 | 0.040 |
Why?
|
Pressure | 3 | 2007 | 1155 | 0.040 |
Why?
|
Adenosine A2 Receptor Antagonists | 1 | 2017 | 49 | 0.040 |
Why?
|
Xanthines | 1 | 2017 | 120 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 1959 | 0.030 |
Why?
|
Middle Aged | 6 | 2024 | 220382 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4567 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 614 | 0.030 |
Why?
|
Synaptophysin | 1 | 2015 | 138 | 0.030 |
Why?
|
Neuromuscular Junction | 1 | 2018 | 403 | 0.030 |
Why?
|
Models, Animal | 1 | 2021 | 2111 | 0.030 |
Why?
|
Prostatectomy | 1 | 2003 | 1821 | 0.030 |
Why?
|
Age Factors | 1 | 2012 | 18379 | 0.030 |
Why?
|
Triazines | 1 | 2017 | 311 | 0.030 |
Why?
|
Health Care Reform | 1 | 2004 | 1245 | 0.030 |
Why?
|
Education, Medical | 1 | 2007 | 1726 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20078 | 0.030 |
Why?
|
Psychiatry | 1 | 2007 | 1690 | 0.030 |
Why?
|
Potassium Channels | 1 | 2017 | 537 | 0.030 |
Why?
|
Motivation | 1 | 2024 | 2006 | 0.030 |
Why?
|
TRPV Cation Channels | 1 | 2015 | 242 | 0.030 |
Why?
|
Pilot Projects | 1 | 2007 | 8611 | 0.030 |
Why?
|
Neurofilament Proteins | 1 | 2015 | 336 | 0.030 |
Why?
|
Bombyx | 1 | 2013 | 58 | 0.030 |
Why?
|
Focus Groups | 1 | 2019 | 1404 | 0.030 |
Why?
|
Psychometrics | 1 | 2022 | 3063 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2022 | 14397 | 0.030 |
Why?
|
X-Ray Microtomography | 1 | 2015 | 450 | 0.030 |
Why?
|
Myosin Light Chains | 1 | 2012 | 121 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2019 | 1301 | 0.020 |
Why?
|
Triazoles | 1 | 2017 | 903 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2013 | 944 | 0.020 |
Why?
|
Urothelium | 1 | 2013 | 269 | 0.020 |
Why?
|
Oxygen | 1 | 2023 | 4222 | 0.020 |
Why?
|
Cell Shape | 1 | 2012 | 370 | 0.020 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2012 | 234 | 0.020 |
Why?
|
Sus scrofa | 1 | 2012 | 428 | 0.020 |
Why?
|
Urologic Surgical Procedures | 1 | 2013 | 298 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2012 | 553 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2003 | 11070 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3331 | 0.020 |
Why?
|
Species Specificity | 1 | 2013 | 2417 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2021 | 80430 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12127 | 0.020 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2012 | 697 | 0.020 |
Why?
|
Organ Specificity | 1 | 2012 | 1956 | 0.020 |
Why?
|
Latex | 1 | 2007 | 49 | 0.020 |
Why?
|
Cytoskeleton | 1 | 2012 | 1167 | 0.020 |
Why?
|
Prevalence | 1 | 2004 | 15698 | 0.020 |
Why?
|
Compliance | 1 | 2007 | 100 | 0.020 |
Why?
|
Sulfonamides | 1 | 2017 | 1973 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2018 | 2629 | 0.020 |
Why?
|
Family | 1 | 2018 | 3189 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2013 | 1689 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1649 | 0.020 |
Why?
|
Down-Regulation | 1 | 2012 | 2911 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 7029 | 0.020 |
Why?
|
Gene Deletion | 1 | 2012 | 2667 | 0.010 |
Why?
|
Metformin | 1 | 2012 | 905 | 0.010 |
Why?
|
Mental Disorders | 1 | 2004 | 6831 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6168 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 2018 | 3220 | 0.010 |
Why?
|
Viscosity | 1 | 2004 | 336 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4116 | 0.010 |
Why?
|
Intestines | 1 | 2012 | 1909 | 0.010 |
Why?
|
Models, Anatomic | 1 | 2007 | 682 | 0.010 |
Why?
|
Prostatic Hyperplasia | 1 | 2007 | 521 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8623 | 0.010 |
Why?
|
Adult | 3 | 2007 | 220781 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2012 | 3026 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2004 | 613 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26063 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4413 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2004 | 1674 | 0.010 |
Why?
|
Linear Models | 1 | 2007 | 5865 | 0.010 |
Why?
|
Adolescent | 1 | 2004 | 88196 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7849 | 0.010 |
Why?
|
Models, Statistical | 1 | 2007 | 5078 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2003 | 15257 | 0.000 |
Why?
|
Algorithms | 1 | 2007 | 14002 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 2003 | 6330 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2003 | 11095 | 0.000 |
Why?
|